that control these processes, nevertheless transitional intermediates and the surface markers that identify them during myelopoiesis are largely undefined.
The transcription factor c-Myb is a critical regulator of hematopoiesis. Indeed, Myb knockout mice die at E15.5 due to severe hematopoietic defects, 6 
and mice harboring hypomorphic
Myb alleles (Myb Plt4/Plt4 mice) have numerous hematopoietic alterations, including supraphysiological platelet production and defects in lymphoid specification. 7, 8 Myb regulates many key genes in myeloid cells (neutrophil elastase, Spi1 (Pu.1), Cebpb, and Runx1) [9] [10] [11] [12] and Myb Plt4/Plt4 mice have increased granulocyte/macrophage colony forming capacity, 7 thus Myb regulates myeloid development.
Siglecs (sialic acid binding, immunoglobulin-like lectins) are a family of cell-surface glycoproteins expressed primarily by innate immune cells. 13, 14 Siglec-F and its human functional paralog Siglec-8, are key surface markers used for the identification of eosinophils. 15, 16 Both Siglec-F and Siglec-8 can be engaged with sialylated glycans (natural and synthetic) or antibodies to induce eosinophil death, [17] [18] [19] [20] although the extent to which Siglec-F-induced apoptosis controls tissue eosinophilia is dependent upon the experimental model used. 21 The natural tissue ligands for Siglec-F include glycan derivatives from Muc5b, a mucin that is constitutively expressed on tracheal epithelial cells. 18 Both SiglecF and Muc5b knockout mice have enhanced allergic eosinophilic inflammation following allergen challenge, 18, 22 suggesting that Muc5b glycans and Siglec-F constitute a negative feedback pathway that helps resolve eosinophilic inflammation. Siglec-F is also expressed on alveolar and peritoneal macrophages, 23, 24 mast cells and dendritic cells in the intestine, 25, 26 and intestinal epithelial (tuft and M) cells, 27, 28 although the function of Siglec-F in these contexts is unclear.
Here, we describe a myeloid progenitor population that expresses Siglec-F, but unlike EoPs, is IL-5-receptor alpha (IL5R ) negative. We show these progenitors to have GMP-like developmental potential in vitro and in vivo, but to be transcriptionally distinct from canonical GMPs. Furthermore, we demonstrate a potential role for Siglec-F in the regulation of GMP viability.
MATERIALS AND METHODS (BRIEF)
Full details are provided as supplementary methods. Summaries are provided below:
Mouse strains
All procedures involving mice were approved by the WEHI Animal Ethics Committee or the Institutional Animal Care and Use Committee of Northwestern University. UBC-GFP mice 29 were obtained from the Jackson Laboratory. Myb Plt4 mice are described in Ref. 7 . PHIL mice (C57BL/6) were provided by Drs. James and Nancy Lee. 30 IL-5 transgenic (IL-5Tg) mice 31 were backcrossed on to a C57BL/6 background.
Flow cytometry
Bone marrow (BM), spleens, blood, and peritoneal cavity lavage cells were collected from 8-12 week old mice. Red blood cells were removed by lysis with an ammonium chloride-based buffer. Cells were stained with cocktails of antibodies recognizing CD11b, IL5R , Siglec-F, B220, CD3, Ly6C, Ly6G, ST2, Lin, cKit, Sca1, Fc RII/III, CD34, and CD45. Cells were resuspended in PBS/2% FCS, 2 mM EDTA, 1 g/ml propidium iodide (Sigma) to enable identification and exclusion of dead cells. Cells were analyzed on a BD LSR Fortessa X-20 flow cytometer (BD Biosciences).
Cell populations were defined using the following surface markers:
Eosinophils (CD11b+ Siglec-F+ IL5R Int SSC Hi ), CMP (Lin-cKit + Sca1-CD34 + Fc RII/III Lo ), GMP (Lin-cKit + Sca1-CD34 + Fc RII/III+), and EoP (Lin-cKit + Sca1-CD34 + Fc RII/III + IL5R +).
Flow cytometric analyses were performed with FlowJo V10 software (FlowJo). Statistical tests and graphs were generated with Prism (GraphPad Software).
Cytocentrifuge preparations
Sorted cells were cytocentrifuged onto glass slides, air dried, fixed with 100% methanol, and stained with May Grünwald's stain (Merck) and 5% Giemsa in pH 6.8 buffered water (Merck) according to manufacturer's instructions.
Colony forming assays
Cells were sorted from the BM of C57BL/6 mice. Colony assays were performed as described in Ref. 32 
and scored by viewing on a Nikon
Optiphot-2 light microscope. 
In vivo developmental potential assays

In vivo Siglec-F ligation
RNA-sequencing
Populations were sorted from the BM of 6-10 week old C57BL/6 and 6 week old Myb Plt4/Plt4 mice. Total RNA was isolated using the RNAeasy Micro Kit (Qiagen). Overall, 130-200 ng total RNA per sample was submitted to the Australian Genome Research Facility for high throughput mRNA-sequencing. Libraries (mRNA) were synthesized using Illumina's TruSeq Stranded mRNA protocol, and 100 bp reads generated with an Illumina HiSeq 2500 (Illumina). Two to five independent RNA samples per cell type were sequenced. Bioinformatic analyses are detailed in supplementary methods.
RESULTS AND DISCUSSION
A Siglec-F+ IL5R − population is present in the BM of wildtype mice
Siglec-F is a signature surface protein found on eosinophils that is used in many laboratories to identify these cells. We have identified a population of cells that is Siglec-F+ but is IL5R − and CD11b+ (Fig. 1A) .
These cells make up 0.56 ± 0.09% (mean ± SEM) of viable cells in the BM, with very few cells falling in this gate in the peripheral blood (Bl), spleen (Spl), or peritoneal cavity (PerC) (0.02 ± 0.001%, 0.02 ± 0.007%, and 0.04 ± 0.001%, respectively) ( Fig. 1A and B ). As eosinophils are typically IL5R + and are known to expand in response to IL-5, we sought to characterize this Siglec-F+ IL5R − population further. The Siglec-F+ IL5R − population has distinct FSC properties, being larger than lymphocytes, eosinophils, or neutrophils ( Supplementary Fig. 1A and B), and side scatter (SSC) properties that are similar to neutrophils, that is having lower SSC than eosinophils and higher SSC than lymphocytes ( Supplementary Fig. 1A and C). Overall, 78.5 ± 1.6% of the cells express CD34, and the cells are cKit Int , ST2−, Fc RII/III+ (Fig. 1C ). Morphologically, these cells have nuclei that in cytocentrifuge preparations appear ellipsoid or monocytoid, with occasional cells exhibiting nuclear segmentation, indicating they are in the myeloid lineage, which is consistent with the CD11b staining ( Fig. 1D ). Upon May Grünwald Giemsa staining, they have a moderate amount of basophilic (purple/blue) cytoplasm and morphologically resemble GMPs.
The Siglec-F+ IL5R − population is present in PHIL mice and is not expanded in IL-5Tg mice
Siglec-F+ IL5R − cells do not have scatter or morphological characteristics of eosinophils, however, they do express the eosinophil marker Siglec-F. We therefore formally tested whether Siglec-F+ IL5R − cells fall within the eosinophil lineage. PHIL mice are devoid of eosinophils and their precursors (EoPs) due to transgenic expression of Diphtheria Toxin A from the Eosinophil Peroxidase promoter, which becomes transcriptionally active in EoPs. 30 PHIL mice retained the Siglec-F+ IL5R − cells, and, similar to wildtype mice, there were approximately 10-fold more Siglec-F+ IL5R − cells in the BM than in any of the peripheral organs examined ( Fig. 2A and B ). Siglec-F+ IL5R − cells are therefore not EoPs, nor are they derived from an Epxexpressing progenitor. Together these data suggest that it is unlikely that Siglec-F+ IL5R − cells lie downstream of an IL-5-responsive precursor; rather they are likely to lie upstream of an EoP or are of a lineage unrelated to eosinophils.
The Siglec-F+ IL5R − population has predominantly neutrophilic developmental potential in vitro and in vivo
Given the morphological similarity of the Siglec-F+ IL5R − cells to GMPs, and their surface expression of cKit, we assessed whether sorted CD11b+ Siglec-F+ IL5R − cells had proliferative potential.
We tested the colony-forming potential of Siglec-F+ IL5R − cells in semi-solid agar cultures with a cocktail of EPO, stem cell factor, and IL-3, which facilitates the development of erythroid, granulocyte, eosinophil, macrophage, megakaryocyte, and blast colonies. Siglec-F+ IL5R − and GMPs both made granulocytic, macrophage, and granulocyte/macrophage colonies (Fig. 3A) , with the GMPs having a higher colony output than the Siglec-F+ IL5R − population. GMPs also generated a small number of blast and eosinophil colonies when plated at this density. The Siglec-F+ IL5R − population also had the potential to make eosinophil colonies when plated at a higher cell density (data not shown). Sorted EoPs (95% purity) made almost exclusively eosinophil colonies.
To examine their in vivo developmental potential, we sorted 
The Siglec-F+ IL5R − population is prominent in Myb mutant mice
Myb knockout mice die during early embryonic development due to severe hematopoietic defects. 6 Hypomorphic Myb mutant mice (Myb Plt4/Plt4 ) generated in our laboratory have increased granulocyte/macrophage colony forming capacity. 7 As shown in Fig. 4A and B, Myb Plt4/Plt4 mice also exhibited a striking increase in the percentage and numbers of CD11b + Siglec-F+ IL5R − cells in the BM. Published ChIP analyses have shown the promoter of Siglec5 (encoding Siglec-F) to be occupied by Myb. 12 We examined the surface expression of Siglec-F on GMPs from C57BL/6 and Myb Plt4/Plt4 mice ( Fig. 4C and D). GMPs have broad Siglec-F expression, which is elevated in Myb mutant cells. These data suggest that Myb negatively regulates Siglec-F expression, and provides a possible mechanism for the prominence of Siglec-F+ GMPs in Myb Plt4/Plt4 mice. 
Siglec-F ligation regulates Siglec-F+ GMP viability and Siglec-F internalization
As engagement of Siglec-F with antibodies can induce modest degrees of eosinophil death in vitro, and a decrease in the number of eosinophils in vivo, 33 we explored whether CD11b+ Siglec-F+ IL5R − cells are affected by Siglec-F ligation. In vivo administration of the anti-Siglec-F antibody 9C7 caused loss of surface Siglec-F expression from CD11b+ cells in the BM, as measured by flow cytometry (Fig. 5A and B). The eosinophil population was restored by Siglec-F intracellular staining (demonstrating Siglec-F internalization), however, CD11b+
Siglec-F+ IL5R − cells were only partially recovered with this technique ( Fig. 5A and B) . The additional loss of CD11b+ Siglec-F+ IL5R − cells following anti-Siglec-F treatment could be explained by three mechanisms: (i) death of Siglec-F+ cells, (ii) shedding or downregula-tion of Siglec-F, and (iii) interference between 9C7 and the E50-2440 clone used for detection. Thus, while anti-Siglec-F treatment did not lead to a statistically significant decrease in eosinophils (as determined by intracellular staining with anti-Siglec-F), it caused a reduction in CD11b+ Siglec-F+ IL5R − cells (p = 0.007).
In addition, we examined the effect of 9C7 on classically gated GMPs. 9C7 treatment reduced surface Siglec-F expression and increased internalization of Siglec-F in GMPs (Fig. 5C ). We found a small but statistically significant increase in dead Siglec-F+ GMPs following 9C7 treatment (Fig. 5D ). Consistent with this finding, Siglec-F+ GMPs have higher levels of Annexin-V binding (in the absence of ligation), an event typically associated with early apoptosis (Fig. 5E ).
Together, these data suggest that Siglec-F ligation can at least partially regulate the viability of Siglec-F+ GMPs. As the Siglec-F+ IL5R − cells had GMP-like developmental potential, we examined the gene expression differences between this population and canonical GMPs. We found 120 genes to be significantly upregulated in the Siglec-F+ IL5R − population (FDR < 0.05); with 230 genes that were downregulated in the Siglec-F+ IL5R − population, relative to GMPs (350 genes in total, Supplementary Table 1 ). This contrasted with the comparison between the Siglec-F+ IL5R − population and EoPs, where > 14-fold more genes were differentially expressed (DE); 3005 genes upregulated and 2143 downregulated (Supplementary Table 2 ). Therefore, transcriptionally, the Siglec-F+ IL5R − cells more closely resemble GMPs than EoPs.
F I G U R E 3 CD11b+ Siglec-F+ IL5R − cells predominantly develop into non-eosinophil granulocytes in vitro and in vivo.
Given the similarities in morphology, and transcriptional profiling between GMPs and the Siglec-F+ IL5R − population, we conducted gene ontology (GO) analyses on the 350 DE genes to better understand differences between the two populations. 34, 35 The most statistically significant GO terms associated with DE genes included 'immune_system_process' (FDR q-value (q) = 1.21 × 10 −54 , 101 genes are marked in Supplementary Table 1) Table 3 ). Of the 416 genes more highly expressed in Myb Plt4/Plt4 cells, 90 were involved with 'immune_system_process' (q = 2.22 × 10 −37 ) and 54 with 'biological_adhesion' (q = 2.42 × 10 −24 ).
Twelve genes associated with integrin signaling, including seven integrins, were upregulated in Myb Plt4/Plt4 cells, suggesting potentially altered binding, adhesion or migratory capabilities. We examined the We particularly noted the differential expression of the transcription factor Irf8 (higher in GMPs than the Siglec-F+ IL5R − population) ( Fig. 6C ). Olsson et al. recently described a large-scale single cell RNAsequencing study performed on sorted GMPs and described Irf8 and Gfi1 as negatively correlated, concluding that Irf8 hi cells were monocytic precursors, and Irf8-(Gfi1 hi ) were specified granulocyte and bipotential precursors. 37 Although this level of specification was not observed in our experiments, we did observe that there was a bias towards the formation of granulocytes by CD11b+ Siglec-F+ IL5R − described a Gata1-positive GMP that was biased towards eosinophil and mast cell specification, and a Gata1-negative GMP biased towards neutrophil and monocyte specification. Our Siglec-F+ IL5R − population has a higher mean expression of Gata1 than GMPs but the expression difference is not statistically significant and the cells are not specified towards eosinophil generation (Fig. 6C ).
In sum, we have described a GMP-like population that expresses Siglec-F, is transcriptionally distinct from GMPs and has predominantly neutrophilic granulocyte potential in cell production assays. Given the increase in Annexin-V staining within the Siglec-F+ GMP gate we propose that Siglec-F may function, at least in part, to regulate viability of this GMP subset. 
